Latest ResMed News & Updates

See the latest news and media coverage for ResMed. We track all announcements, press releases, and industry mentions in real time, all in one place.

ResMed

Medical technology company for sleep and respiratory care

resmed.com

Headquarters: San Diego, United States
Company type: Public company
Number of employees: 9,000–10,000
Industry: Medical Equipment, Supplies & Distribution

Last updated Today

Latest news about ResMed

In short: ResMed reported record fiscal 2026 revenue of $5.7 billion, acquired Noctrix Health, and divested MatrixCare to refocus on core sleep care.

Company announcements

August 17 ResMed

ResMed appoints Carol Burt as lead director

Carol Burt succeeds retiring board member Ron Taylor after his 21-year tenure, effective November 15, 2026.

August 14 ResMed

ResMed CEO awarded Singapore's Public Service Star

The award recognizes ResMed's contributions over 20 years in Singapore, including advanced manufacturing and R&D expansion.

July 7 ResMed

ResMed announces agreement to sell MatrixCare business

Sharpens focus on high-growth sleep and connected care markets.

June 1 ResMed

ResMed completes acquisition of Noctrix Health

The deal adds Nidra TOMAC therapy for Restless Legs Syndrome.

Media coverage

Yesterday Yahoo Finance

This Analyst Just Upgraded ResMed Stock. Here's Why.

ResMed stock rallies on a bullish RBC Capital research note. Here's why analyst Craig Wong-Pan raised his price target on RMD shares today.

September 14 Yahoo Finance

Patient Monitoring Stocks Q2 Teardown: ResMed (NYSE:RMD) Vs The Rest

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the patient monitoring stocks,...

September 1 Switzer

Is Ozempic finally helping or still just hurting ResMed?

"injectable glucagon-like peptide-1, or GLP-1, weight loss drugs may lower the occurrence of obesity, eventually reducing the severity of OSA, if significant weight loss is...

September 1 Marketscreener

ResMed Enters $450 Million Accelerated Share Repurchase Agreement With Citibank; Shares Fall 3%

ResMed has entered into a $450 million accelerated share repurchase agreement with Citibank on Monday to repurchase shares of its common stock, according to a...

Never miss news about ResMed

Track ResMed and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

ResMed competitors & trending companies

Browse news for competitors to ResMed and other trending companies.